Johns Hopkins University: Tuberculosis trials
The registry lists 31 Tuberculosis studies with Johns Hopkins University as lead sponsor. 2 are open to participants now and 10 have results posted.
Phase 1 3Phase 2 7Phase 3 2Phase 4 2No phase 18(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentRecruitingNCT06497465Phase 3
- Shortened Regimen for Drug-susceptible TB in ChildrenRecruitingNCT06253715Phase 3
- Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South AfricaCompletedNCT06739915Not applicableResults posted
- Ultra Curto (Ultra Short) TB Prevention TherapyCompletedNCT04703075Phase 4Results posted
- Prevent TB: Choice Architecture for TPT DeliveryCompletedNCT04466488Not applicableResults posted
- Statin Adjunctive Therapy for TBCompletedNCT03456102Phase 2Results posted
- Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TBCompletedNCT03174184Phase 2Results posted
- Assessing PA-824 for Tuberculosis (the APT Trial)CompletedNCT02256696Phase 2Results posted
- Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy VolunteersCompletedNCT01162486Phase 1Results posted
- Study of Daily Rifapentine for Pulmonary TuberculosisCompletedNCT00814671Phase 2Results posted
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary TuberculosisTerminatedNCT00728507Phase 2Results posted
- Moxifloxacin As Part of a Multi-Drug Regimen For TuberculosisCompletedNCT00082173Phase 2Results posted
- Clinical Practice Guidelines Versus Decision-support for Latent Tuberculosis Infection (LTBI) ManagementCompletedNCT05772065Not applicable
- Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PETCompletedNCT05609552
- Clinic-based Versus Hotspot-focused Active TB Case FindingCompletedNCT05285202Not applicable
- Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB TrialCompletedNCT04494516
- Choice Architecture Based TB Preventive Therapy PrescribingCompletedNCT04466293Not applicable
- Community Initiated Preventive Therapy for TBCompletedNCT04369326Not applicable
- Tuberculosis (TB) AftermathCompletedNCT04333485Not applicable
- Alcohol Reduction Among People With TB and HIV in IndiaActive, not recruitingNCT04230395Not applicable
- Nurse-Led, Symptom-Based Screening of Household Child Contacts of Tuberculosis Index CasesCompletedNCT03074799Not applicable
- Optimizing Treatment to Improve TBM Outcomes in ChildrenCompletedNCT02958709Phase 1/2
- Screening for TB in Pregnancy. on HIV-Infected Pregnant WomenCompletedNCT02520973Not applicable
- Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification TestsCompletedNCT02252198
- Feasibility and Accuracy of a Novel Xpert CartridgeCompletedNCT02251327
- A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment OutcomesCompletedNCT02238405Not applicable
- Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South AfricaCompletedNCT02119130Not applicable
- Chepetsa TB - Reducing TB Among HIV-Infected MalawiansCompletedNCT01450085Not applicable
- Innovative Approaches to Tuberculosis ControlCompletedNCT00472316
- Pharmacokinetic Issues of Moxifloxacin Plus RifapentineTerminatedNCT00460759Phase 1
- TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)CompletedNCT00107887Phase 4